226 related articles for article (PubMed ID: 32911250)
21. Expanding spectrum of contactin-associated protein 2 (CASPR2) autoimmunity-syndrome of parkinsonism and ataxia.
Kannoth S; Nambiar V; Gopinath S; Anandakuttan A; Mathai A; Rajan PK
Neurol Sci; 2018 Mar; 39(3):455-460. PubMed ID: 29264691
[TBL] [Abstract][Full Text] [Related]
22. Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia.
Vincent A; Pettingill P; Pettingill R; Lang B; Birch R; Waters P; Irani SR; Buckley C; Watanabe O; Arimura K; Kiernan MC
JAMA Neurol; 2018 Dec; 75(12):1519-1527. PubMed ID: 30242309
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies).
Bastiaansen AEM; van Sonderen A; Titulaer MJ
Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701
[TBL] [Abstract][Full Text] [Related]
24. From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time.
van Sonderen A; Schreurs MW; Wirtz PW; Sillevis Smitt PA; Titulaer MJ
Autoimmun Rev; 2016 Oct; 15(10):970-4. PubMed ID: 27485013
[TBL] [Abstract][Full Text] [Related]
25. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping.
Klein CJ; Lennon VA; Aston PA; McKeon A; O'Toole O; Quek A; Pittock SJ
JAMA Neurol; 2013 Feb; 70(2):229-34. PubMed ID: 23407760
[TBL] [Abstract][Full Text] [Related]
26. Serum and CSF cytokine levels mirror different neuroimmunological mechanisms in patients with LGI1 and Caspr2 encephalitis.
Körtvelyessy P; Goihl A; Guttek K; Schraven B; Prüss H; Reinhold D
Cytokine; 2020 Nov; 135():155226. PubMed ID: 32799011
[TBL] [Abstract][Full Text] [Related]
27. Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis.
Gövert F; Abrante L; Becktepe J; Balint B; Ganos C; Hofstadt-van Oy U; Krogias C; Varley J; Irani SR; Paneva S; Titulaer MJ; de Vries JM; Boon AJW; Schreurs MWJ; Joubert B; Honnorat J; Vogrig A; Ariño H; Sabater L; Dalmau J; Scotton S; Jacob S; Melzer N; Bien CG; Geis C; Lewerenz J; Prüss H; Wandinger KP; Deuschl G; Leypoldt F
Brain; 2023 Feb; 146(2):657-667. PubMed ID: 35875984
[TBL] [Abstract][Full Text] [Related]
28. Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex.
Montojo MT; Petit-Pedrol M; Graus F; Dalmau J
Neurologia; 2015 Jun; 30(5):295-301. PubMed ID: 24485651
[TBL] [Abstract][Full Text] [Related]
29. Guillain-Barré-like syndrome: an uncommon feature of CASPR2 and LGI1 autoimmunity.
Tan X; Liu Y; Wu X; Guo Y
J Neurol; 2022 Nov; 269(11):5893-5900. PubMed ID: 35781606
[TBL] [Abstract][Full Text] [Related]
30. Morvan syndrome associated with LGI1 antibody: a case report.
Zhang SJ; Xue YY; Yu H; Tao QQ
BMC Neurol; 2021 May; 21(1):185. PubMed ID: 33941099
[TBL] [Abstract][Full Text] [Related]
31. Acquired neuromyotonia in children with CASPR2 and LGI1 antibodies.
Surana S; Kumar R; Pitt M; Hafner P; Mclellan A; Davidson J; Prabakhar P; Vincent A; Hacohen Y; Wright S
Dev Med Child Neurol; 2019 Nov; 61(11):1344-1347. PubMed ID: 30724344
[TBL] [Abstract][Full Text] [Related]
32. Hippocampal epileptogenesis in autoimmune encephalitis.
Romoli M; Krashia P; Sen A; Franciotta D; Gastaldi M; Nobili A; Mancini A; Nardi Cesarini E; Nigro P; Tambasco N; Mercuri NB; Parnetti L; Di Filippo M; D'Amelio M; Irani SR; Costa C; Calabresi P
Ann Clin Transl Neurol; 2019 Nov; 6(11):2261-2269. PubMed ID: 31617317
[TBL] [Abstract][Full Text] [Related]
33. Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features.
Muñiz-Castrillo S; Joubert B; Elsensohn MH; Pinto AL; Saint-Martin M; Vogrig A; Picard G; Rogemond V; Dubois V; Tamouza R; Maucort-Boulch D; Honnorat J
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1076-1084. PubMed ID: 32651251
[TBL] [Abstract][Full Text] [Related]
34. Risk of Seizure Recurrence Due to Autoimmune Encephalitis With NMDAR, LGI1, CASPR2, and GABA
Rada A; Hagemann A; Aaberg Poulsen C; Baumgartner T; Berki T; Blaabjerg M; Brenner J; Britton JW; Christiana A; Ciano-Petersen NL; Crijnen Y; Elišák M; Farina A; Friedman AR; Hayden Z; Hébert J; Holtkamp M; Hong Z; Honnorat J; Ilyas-Feldmann M; Irani SR; Kovac S; Marusic P; Muñiz-Castrillo S; Ramanathan S; Smith KM; Steriade C; Strippel C; Surges R; Titulaer MJ; Uy CE; de Vries JM; Bien CG; Specht U
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200225. PubMed ID: 38838283
[TBL] [Abstract][Full Text] [Related]
35. Objective sleep profile in LGI1/CASPR2 autoimmunity.
Devine MF; Feemster JC; Lieske EA; McCarter SJ; Sandness DJ; Steele T; Timm PC; Mandrekar J; Boeve BF; Silber MH; Dubey D; McKeon A; St Louis EK
Sleep; 2022 Feb; 45(2):. PubMed ID: 34953167
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal CSF Findings in Autoimmune Encephalitis-A Monocentric Cohort Study.
Zrzavy T; Höftberger R; Wimmer I; Berger T; Rommer P; Macher S
Front Immunol; 2021; 12():646940. PubMed ID: 33828556
[TBL] [Abstract][Full Text] [Related]
37. LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes.
Binks SNM; Klein CJ; Waters P; Pittock SJ; Irani SR
J Neurol Neurosurg Psychiatry; 2018 May; 89(5):526-534. PubMed ID: 29055902
[TBL] [Abstract][Full Text] [Related]
38. [Morvan syndrome with positive anti LGI1/CASPR2 antibodies in serum/cerebrospinal fluid:a case report and literature review].
Zhao LT; Yu YX; Qian HR; Yao S; Han XC; Liu XK; Qi X
Zhonghua Nei Ke Za Zhi; 2022 Jun; 61(6):678-681. PubMed ID: 35673749
[TBL] [Abstract][Full Text] [Related]
39. Caspr2 antibody limbic encephalitis is associated with Hashimoto thyroiditis and thymoma.
Lee CH; Lin JJ; Lin KJ; Chang BL; Hsieh HY; Chen WH; Lin KL; Fung HC; Wu T
J Neurol Sci; 2014 Jun; 341(1-2):36-40. PubMed ID: 24726720
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study.
Celicanin M; Blaabjerg M; Maersk-Moller C; Beniczky S; Marner L; Thomsen C; Bach FW; Kondziella D; Andersen H; Somnier F; Illes Z; Pinborg LH
Eur J Neurol; 2017 Aug; 24(8):999-1005. PubMed ID: 28544133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
